Read More 1 minute read Analyst Ratings News Price Target Goldman Sachs Maintains Buy on General Electric, Raises Price Target to $96 By Benzinga Newsdesk Today, 9:41 PM Goldman Sachs analyst Joe Ritchie maintains General Electric (NYSE:GE) with a Buy and raises the price target from $84 to $96. GE
Read More 1 minute read Analyst Ratings News Price Target Goldman Sachs Maintains Buy on Fulcrum Therapeutics, Lowers Price Target to $9 By Benzinga Newsdesk Today, 9:41 PM Goldman Sachs analyst Madhu Kumar maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Buy and lowers the price target from $17 to $9. FULC
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on PennantPark Floating Rate, Maintains $12 Price Target By Benzinga Newsdesk Today, 9:41 PM JMP Securities analyst Kevin Fitzsimmons reiterates PennantPark Floating Rate (NYSE:PFLT) with a Market Outperform and maintains $12 price target. PFLT
Read More 1 minute read Analyst Ratings News Price Target Reiteration Wedbush Reiterates Outperform on Cognizant Tech Solns, Maintains $75 Price Target By Benzinga Newsdesk Today, 9:41 PM Wedbush analyst Moshe Katri reiterates Cognizant Tech Solns (NASDAQ:CTSH) with a Outperform and maintains $75 price target. CTSH
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Marketwise, Maintains $6 Price Target By Benzinga Newsdesk Today, 9:41 PM JMP Securities analyst Devin Ryan reiterates Marketwise (NASDAQ:MKTW) with a Market Outperform and maintains $6 price target. MKTW
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on LPL Finl Hldgs, Maintains $290 Price Target By Benzinga Newsdesk Today, 9:41 PM JMP Securities analyst Devin Ryan reiterates LPL Finl Hldgs (NASDAQ:LPLA) with a Market Outperform and maintains $290 price target. LPLA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Neutral on ACADIA Pharmaceuticals, Maintains $19 Price Target By Benzinga Newsdesk Today, 9:41 PM Mizuho analyst Uy Ear reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and maintains $19 price target. ACAD
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Oatly Group, Maintains $7 Price Target By Benzinga Newsdesk Today, 9:41 PM RBC Capital analyst Nik Modi reiterates Oatly Group (NASDAQ:OTLY) with a Outperform and maintains $7 price target. OTLY
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Adobe, Maintains $395 Price Target By Benzinga Newsdesk Today, 9:41 PM RBC Capital analyst Matthew Hedberg reiterates Adobe (NASDAQ:ADBE) with a Outperform and maintains $395 price target. ADBE
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Sector Perform on UiPath, Maintains $15 Price Target By Benzinga Newsdesk Today, 9:41 PM RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:PATH) with a Sector Perform and maintains $15 price target. PATH